Why Is HIMS & HERS HEALTH I A (HIMS) Stock Up Today?

HIMS stock surged 7.29% to $29.80 in early trading on July 21, driven by a large call options print and a rebound from a recent price decline. The stock opened at $27.85 and reached a session high of $29.91 before settling near the top of the range. The unusual options activity suggests a significant bullish bet, while the stock’s 14.4% drop over the prior eight sessions appears to have triggered a short-term rebound.

What Happened

Late July 2026 short interest data highlighted HIMS as a heavily shorted stock, with bearish bets increasing amid concerns over dilution and ongoing losses. This context may have contributed to a short-covering rally, especially after the stock had fallen from $32.29 to $27.65 in the previous week. The single notable options print of $6.3 million in call premium, far exceeding the $0 in put premium, indicates a strong institutional or large retail investor positioning for a near-term price rise. The stock’s 52-week range of $13.74 to $70.43 suggests the current price remains well below its peak, but above the recent trough.

What The Data Shows

The stock traded at 0.1x its 3-month average volume, indicating limited participation despite the sharp move. Over the last 90 days, insiders have sold $3.9 million in shares compared to $1.2 million in purchases, with the CFO selling on three occasions in June and July. The company reported a net loss in its trailing twelve months with an EPS of -0.06 and a net margin of -0.6%, but revenue grew 32.8% year-to-date. The stock’s beta of 2.34 reflects high volatility, and its market cap of $6.4 billion remains under pressure from ongoing legal risks, including an FTC lawsuit over data sharing practices.

What To Watch

The stock is not scheduled to report earnings in the near term. Investors should monitor coverage breadth and any follow-up on the FTC lawsuit, as well as whether the recent options activity leads to sustained buying interest.